Key result
Obesity exacerbates insulin resistance, alters hormonal profiles, and delays response to infertility treatments in patients with polycystic ovary syndrome.
Obesity significantly alters the hormonal and metabolic profile of PCOS patients, suggesting it should be considered a key characteristic for classifying PCOS phenotypes.
Supports obesity-informed PCOS phenotyping now; extends metabolic evidence but leaves open prospective validation for fertility outcomes.
Obesity or overweight affect most of patients with polycystic ovary syndrome (PCOS). Phenotypes are the clinical characteristics produced by the interaction of heredity and environment in a disease or syndrome. Phenotypes of PCOS have been described on the presence of clinical hyperandrogenism, oligoovulation and polycystic ovaries. The insulin resistance is present in the majority of patients with obesity and/or PCOS and it is more frequent and of greater magnitude in obese than in non obese PCOS patients. Levels of sexual hormone binding globulin are decreased, and levels of free androgens are increased in obese PCOS patients. Weight loss treatment is important for overweight or obese PCOS patients, but not necessary for normal weight PCOS patients, who only need to avoid increasing their body weight. Obesity decreases or delays several infertility treatments. The differences in the hormonal and metabolic profile, as well as the different focus and response to treatment between obese and non obese PCOS patients suggest that obesity has to be considered as a characteristic for classification of PCOS phenotypes.
No takes yet. Share an insight, caveat, or question.
Morán et al. (2012) conducted a review in Polycystic ovary syndrome. Obesity vs. Non-obese was evaluated. Obesity exacerbates insulin resistance, alters hormonal profiles, and delays response to infertility treatments in patients with polycystic ovary syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: